Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 1998

View Archived Issues

Effects of EAA receptor antagonists on morphine tolerance and dependence

Company Profile: Andrx

KBR-7943, a novel Na+/Ca2+ exchange inhibitor

Benefits of finasteride in patients with benign prostatic hyperplasia

JTV-506, a potential antianginal agent

Beneficial effects of aspirin on endothelial dysfunction in patients with atherosclerosis

The role of ETA and ETB receptor subtypes in human blood vessels

DepoTech: Q4 and year-end 1997 highlights

Neurex: year-end 1997 highlights

Lilly antifolate evaluated in phase II

Favorable phase I results obtained with G-3139 in NHL

S-1 demonstrates excellent antitumor activity in phase II

Overview of preclinical and clinical evaluation of Russian nitrosourea

Viracept approved in Japan

Evidence of clinical efficacy of ukrain in colorectal cancer

Entropin goes public

Anticancer imidazoles from Merck & Co.

DepoCyt FDA review period extended in order to review additional patient data

Roche finalizes Corange acquisition

Once-a-day Cozaar introduced in Canada

Ritonavir in advanced HIV-1 disease

Antithromboxane therapy leads to clinical benefit in type II diabetics

New cisapride formulation introduced in U.K.

DepoMed, R.W. Johnson sign research agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...